Client News

Abivax Presents Business Updates and First Half 2026 Financial Result

InflaRx to Host Virtual Capital Markets Day

Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101

QuE-MRT Enters Its Next Phase: Progress in Quantum-Enhanced MRI in Germany

Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress

Mallia Aesthetics Presents Data on the Role of sCD83 in Hair Growth at Third Barcelona Hair Meeting

CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange™

InflaRx Announces Participation in September Investor Conferences

Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones